-
Study aim
-
Reduction of nausea and vomiting after surgery
-
Design
-
Clinical trial with a control group, with parallel groups, double-blind, randomized, phase 2 on 60 patients. spss software was used for randomization.
-
Settings and conduct
-
This study will be a double-blind, randomized controlled clinical trial in which the patient and the anesthesiologist are unaware of the type of injected drug.the present study includes patients visiting the center. Razi medical training in Ahvaz province in the year 1402-1401, which has an indication for cesarean section and they are placed under spinal anesthesia under cesarean section.To carry out this plan, 60 patients will be considered for cesarean section with spinal anesthesia in the operating room. In this study, two groups, including group D, which receives 0.1 mg/kg of dexamethasone, and group p, which includes recipients of the same amount of normal saline, will be included as the placebo group.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Pregnant women with cesarean indications; Consent to participate in the study; Age range from 18 to 40 years; Adequate level of anesthesia; ASA class 1 and ASA class 2; No history of HTN pregnancy. Exit criteria: Lack of patient consent to participate in the study; Reaching the level of anesthesia above T4; Patients with pre-pregnancy hypertension, pre-eclampsia and eclampsia; Presence of drug allergy.
-
Intervention groups
-
In this study, two groups, including group D, which receives 0.1 mg/kg of dexamethasone, and group p, which includes recipients of the same amount of normal saline, will be included as the placebo group. And the effect of the drug is measured in reducing nausea and vomiting
-
Main outcome variables
-
Nausea; vomiting